Matches in Wikidata for { <http://www.wikidata.org/entity/Q90046433> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q90046433 description "artículu científicu espublizáu n'abril de 2019" @default.
- Q90046433 description "scientific article published on 01 April 2019" @default.
- Q90046433 description "wetenschappelijk artikel" @default.
- Q90046433 description "наукова стаття, опублікована 1 квітня 2019" @default.
- Q90046433 name "Efficacy and safety of nintedanib + docetaxel in lung adenocarcinoma patients (pts) following treatment with immune checkpoint inhibitors (ICIs): First results of the ongoing non-interventional study (NIS) VARGADO" @default.
- Q90046433 name "Efficacy and safety of nintedanib + docetaxel in lung adenocarcinoma patients (pts) following treatment with immune checkpoint inhibitors (ICIs): First results of the ongoing non-interventional study (NIS) VARGADO" @default.
- Q90046433 type Item @default.
- Q90046433 label "Efficacy and safety of nintedanib + docetaxel in lung adenocarcinoma patients (pts) following treatment with immune checkpoint inhibitors (ICIs): First results of the ongoing non-interventional study (NIS) VARGADO" @default.
- Q90046433 label "Efficacy and safety of nintedanib + docetaxel in lung adenocarcinoma patients (pts) following treatment with immune checkpoint inhibitors (ICIs): First results of the ongoing non-interventional study (NIS) VARGADO" @default.
- Q90046433 prefLabel "Efficacy and safety of nintedanib + docetaxel in lung adenocarcinoma patients (pts) following treatment with immune checkpoint inhibitors (ICIs): First results of the ongoing non-interventional study (NIS) VARGADO" @default.
- Q90046433 prefLabel "Efficacy and safety of nintedanib + docetaxel in lung adenocarcinoma patients (pts) following treatment with immune checkpoint inhibitors (ICIs): First results of the ongoing non-interventional study (NIS) VARGADO" @default.
- Q90046433 P1433 Q90046433-8D90F9BB-FFB6-43FF-A101-645C0F332559 @default.
- Q90046433 P1476 Q90046433-D1093CB0-73FF-4FED-869A-AADA194C4F61 @default.
- Q90046433 P2093 Q90046433-153DB368-D78D-4E45-979F-3C435CBA4CEA @default.
- Q90046433 P2093 Q90046433-546EE559-5485-4F71-804B-4013C2962B72 @default.
- Q90046433 P2093 Q90046433-5C15F939-D5EB-45D9-969B-76BED6E337BC @default.
- Q90046433 P2093 Q90046433-779A51EF-939E-4329-A73C-838E7B3B0905 @default.
- Q90046433 P2093 Q90046433-792DAD64-7508-4567-964C-0FE6B9E6C7A1 @default.
- Q90046433 P2093 Q90046433-8377C752-FF53-4BF6-A9F7-C6D83315CB13 @default.
- Q90046433 P2093 Q90046433-898D6C22-D624-497F-B831-3B8B67DE6A4A @default.
- Q90046433 P304 Q90046433-F82C1A4A-E276-4933-A130-A86724875949 @default.
- Q90046433 P31 Q90046433-1E0E80E8-0F17-4612-B3B7-C804F1DC2278 @default.
- Q90046433 P356 Q90046433-60F70EDF-FEB6-4CE9-ABA9-A3619E312F8C @default.
- Q90046433 P478 Q90046433-847A22F9-621C-440D-8BD8-C65DE9A4BFBF @default.
- Q90046433 P577 Q90046433-C84E4CCB-79B1-42F5-BA9A-AE72171B8A03 @default.
- Q90046433 P921 Q90046433-8674E5A1-77EA-4E84-91E2-01E2C8CF26AE @default.
- Q90046433 P356 MDZ063.017 @default.
- Q90046433 P1433 Q326122 @default.
- Q90046433 P1476 "Efficacy and safety of nintedanib + docetaxel in lung adenocarcinoma patients (pts) following treatment with immune checkpoint inhibitors (ICIs): First results of the ongoing non-interventional study (NIS) VARGADO" @default.
- Q90046433 P2093 "C Grohe" @default.
- Q90046433 P2093 "H Mueller-Huesmann" @default.
- Q90046433 P2093 "J Atz" @default.
- Q90046433 P2093 "M Schulze" @default.
- Q90046433 P2093 "R Kaiser" @default.
- Q90046433 P2093 "S Haas" @default.
- Q90046433 P2093 "W Gleiber" @default.
- Q90046433 P304 "ii48" @default.
- Q90046433 P31 Q13442814 @default.
- Q90046433 P356 "10.1093/ANNONC/MDZ063.017" @default.
- Q90046433 P478 "30 Suppl 2" @default.
- Q90046433 P577 "2019-04-01T00:00:00Z" @default.
- Q90046433 P921 Q420436 @default.